img

Global Biopharmaceutical CDMO Service Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Biopharmaceutical CDMO Service Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Biopharmaceutical CDMO Service Market
Global Biopharmaceutical CDMO Service market is expected to reach to US$ 16570 million in 2023, with a positive growth of %, compared with US$ 14640 million in 2022. Backed with the increasing demand from downstream industries, Biopharmaceutical CDMO Service industry is evaluated to reach US$ 29770 million in 2033. The CAGR will be 10.3% during 2023 to 2033.
Globally, Biopharmaceutical CDMO Service key companies include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc. KBI Biopharma, INCOG BioPharma Services, CordenPharma are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Biopharmaceutical CDMO Service were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biopharmaceutical CDMO Service market and estimated to attract more attentions from industry insiders and investors.
Biopharmaceutical CDMO Service can be divided into Develop Innovative Drugs, Listed Patented Drug, Biosimilars and Others, etc. Develop Innovative Drugs is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Biopharmaceutical CDMO Service is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Biopharmaceutical CDMO Service industry development. In 2022, global % revenue of Biopharmaceutical CDMO Service went into Pharmaceutical Company filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biopharmaceutical CDMO Service market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biopharmaceutical CDMO Service market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Segment by Type
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others

Segment by Application


Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biopharmaceutical CDMO Service introduction, etc. Biopharmaceutical CDMO Service Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biopharmaceutical CDMO Service
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CDMO Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Develop Innovative Drugs
1.2.3 Listed Patented Drug
1.2.4 Biosimilars
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CDMO Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CDMO Service Market Perspective (2018-2033)
2.2 Global Biopharmaceutical CDMO Service Growth Trends by Region
2.2.1 Biopharmaceutical CDMO Service Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biopharmaceutical CDMO Service Historic Market Size by Region (2018-2023)
2.2.3 Biopharmaceutical CDMO Service Forecasted Market Size by Region (2024-2033)
2.3 Biopharmaceutical CDMO Service Market Dynamics
2.3.1 Biopharmaceutical CDMO Service Industry Trends
2.3.2 Biopharmaceutical CDMO Service Market Drivers
2.3.3 Biopharmaceutical CDMO Service Market Challenges
2.3.4 Biopharmaceutical CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biopharmaceutical CDMO Service by Players
3.1.1 Global Biopharmaceutical CDMO Service Revenue by Players (2018-2023)
3.1.2 Global Biopharmaceutical CDMO Service Revenue Market Share by Players (2018-2023)
3.2 Global Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biopharmaceutical CDMO Service, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biopharmaceutical CDMO Service Market Concentration Ratio
3.4.1 Global Biopharmaceutical CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CDMO Service Revenue in 2022
3.5 Global Key Players of Biopharmaceutical CDMO Service Head office and Area Served
3.6 Global Key Players of Biopharmaceutical CDMO Service, Product and Application
3.7 Global Key Players of Biopharmaceutical CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CDMO Service Breakdown Data by Type
4.1 Global Biopharmaceutical CDMO Service Historic Market Size by Type (2018-2023)
4.2 Global Biopharmaceutical CDMO Service Forecasted Market Size by Type (2024-2033)
5 Biopharmaceutical CDMO Service Breakdown Data by Application
5.1 Global Biopharmaceutical CDMO Service Historic Market Size by Application (2018-2023)
5.2 Global Biopharmaceutical CDMO Service Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biopharmaceutical CDMO Service Market Size (2018-2033)
6.2 North America Biopharmaceutical CDMO Service Market Size by Type
6.2.1 North America Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
6.2.2 North America Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
6.2.3 North America Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
6.3 North America Biopharmaceutical CDMO Service Market Size by Application
6.3.1 North America Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
6.3.2 North America Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
6.3.3 North America Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
6.4 North America Biopharmaceutical CDMO Service Market Size by Country
6.4.1 North America Biopharmaceutical CDMO Service Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Biopharmaceutical CDMO Service Market Size by Country (2018-2023)
6.4.3 North America Biopharmaceutical CDMO Service Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Biopharmaceutical CDMO Service Market Size (2018-2033)
7.2 Europe Biopharmaceutical CDMO Service Market Size by Type
7.2.1 Europe Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
7.2.2 Europe Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
7.2.3 Europe Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
7.3 Europe Biopharmaceutical CDMO Service Market Size by Application
7.3.1 Europe Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
7.3.2 Europe Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
7.3.3 Europe Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
7.4 Europe Biopharmaceutical CDMO Service Market Size by Country
7.4.1 Europe Biopharmaceutical CDMO Service Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Biopharmaceutical CDMO Service Market Size by Country (2018-2023)
7.4.3 Europe Biopharmaceutical CDMO Service Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biopharmaceutical CDMO Service Market Size (2018-2033)
8.2 China Biopharmaceutical CDMO Service Market Size by Type
8.2.1 China Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
8.2.2 China Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
8.2.3 China Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
8.3 China Biopharmaceutical CDMO Service Market Size by Application
8.3.1 China Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
8.3.2 China Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
8.3.3 China Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Biopharmaceutical CDMO Service Market Size (2018-2033)
9.2 Asia Biopharmaceutical CDMO Service Market Size by Type
9.2.1 Asia Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
9.2.2 Asia Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
9.2.3 Asia Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
9.3 Asia Biopharmaceutical CDMO Service Market Size by Application
9.3.1 Asia Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
9.3.2 Asia Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
9.3.3 Asia Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
9.4 Asia Biopharmaceutical CDMO Service Market Size by Region
9.4.1 Asia Biopharmaceutical CDMO Service Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Biopharmaceutical CDMO Service Market Size by Region (2018-2023)
9.4.3 Asia Biopharmaceutical CDMO Service Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 KBI Biopharma
11.1.1 KBI Biopharma Company Details
11.1.2 KBI Biopharma Business Overview
11.1.3 KBI Biopharma Biopharmaceutical CDMO Service Introduction
11.1.4 KBI Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.1.5 KBI Biopharma Recent Developments
11.2 INCOG BioPharma Services
11.2.1 INCOG BioPharma Services Company Details
11.2.2 INCOG BioPharma Services Business Overview
11.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Introduction
11.2.4 INCOG BioPharma Services Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.2.5 INCOG BioPharma Services Recent Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Details
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Biopharmaceutical CDMO Service Introduction
11.3.4 CordenPharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.3.5 CordenPharma Recent Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Details
11.4.2 AGC Biologics Business Overview
11.4.3 AGC Biologics Biopharmaceutical CDMO Service Introduction
11.4.4 AGC Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.4.5 AGC Biologics Recent Developments
11.5 Northway Biotech
11.5.1 Northway Biotech Company Details
11.5.2 Northway Biotech Business Overview
11.5.3 Northway Biotech Biopharmaceutical CDMO Service Introduction
11.5.4 Northway Biotech Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.5.5 Northway Biotech Recent Developments
11.6 PlantForm Corp
11.6.1 PlantForm Corp Company Details
11.6.2 PlantForm Corp Business Overview
11.6.3 PlantForm Corp Biopharmaceutical CDMO Service Introduction
11.6.4 PlantForm Corp Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.6.5 PlantForm Corp Recent Developments
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza Biopharmaceutical CDMO Service Introduction
11.7.4 Lonza Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.7.5 Lonza Recent Developments
11.8 ADL Biopharma
11.8.1 ADL Biopharma Company Details
11.8.2 ADL Biopharma Business Overview
11.8.3 ADL Biopharma Biopharmaceutical CDMO Service Introduction
11.8.4 ADL Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.8.5 ADL Biopharma Recent Developments
11.9 Catalent
11.9.1 Catalent Company Details
11.9.2 Catalent Business Overview
11.9.3 Catalent Biopharmaceutical CDMO Service Introduction
11.9.4 Catalent Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.9.5 Catalent Recent Developments
11.10 Future Fields
11.10.1 Future Fields Company Details
11.10.2 Future Fields Business Overview
11.10.3 Future Fields Biopharmaceutical CDMO Service Introduction
11.10.4 Future Fields Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.10.5 Future Fields Recent Developments
11.11 Vetter Pharma
11.11.1 Vetter Pharma Company Details
11.11.2 Vetter Pharma Business Overview
11.11.3 Vetter Pharma Biopharmaceutical CDMO Service Introduction
11.11.4 Vetter Pharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.11.5 Vetter Pharma Recent Developments
11.12 Stelis
11.12.1 Stelis Company Details
11.12.2 Stelis Business Overview
11.12.3 Stelis Biopharmaceutical CDMO Service Introduction
11.12.4 Stelis Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.12.5 Stelis Recent Developments
11.13 Richter-Helm
11.13.1 Richter-Helm Company Details
11.13.2 Richter-Helm Business Overview
11.13.3 Richter-Helm Biopharmaceutical CDMO Service Introduction
11.13.4 Richter-Helm Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.13.5 Richter-Helm Recent Developments
11.14 FUJIFILM Diosynth Biotechnologies
11.14.1 FUJIFILM Diosynth Biotechnologies Company Details
11.14.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Introduction
11.14.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.15 Cambrex
11.15.1 Cambrex Company Details
11.15.2 Cambrex Business Overview
11.15.3 Cambrex Biopharmaceutical CDMO Service Introduction
11.15.4 Cambrex Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.15.5 Cambrex Recent Developments
11.16 Pfizer CentreOne
11.16.1 Pfizer CentreOne Company Details
11.16.2 Pfizer CentreOne Business Overview
11.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Introduction
11.16.4 Pfizer CentreOne Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.16.5 Pfizer CentreOne Recent Developments
11.17 Samsung Biologics
11.17.1 Samsung Biologics Company Details
11.17.2 Samsung Biologics Business Overview
11.17.3 Samsung Biologics Biopharmaceutical CDMO Service Introduction
11.17.4 Samsung Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
11.17.5 Samsung Biologics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biopharmaceutical CDMO Service Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Develop Innovative Drugs
Table 3. Key Players of Listed Patented Drug
Table 4. Key Players of Biosimilars
Table 5. Key Players of Others
Table 6. Global Biopharmaceutical CDMO Service Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Biopharmaceutical CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Biopharmaceutical CDMO Service Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Biopharmaceutical CDMO Service Market Share by Region (2018-2023)
Table 10. Global Biopharmaceutical CDMO Service Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Biopharmaceutical CDMO Service Market Share by Region (2024-2033)
Table 12. Biopharmaceutical CDMO Service Market Trends
Table 13. Biopharmaceutical CDMO Service Market Drivers
Table 14. Biopharmaceutical CDMO Service Market Challenges
Table 15. Biopharmaceutical CDMO Service Market Restraints
Table 16. Global Biopharmaceutical CDMO Service Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Biopharmaceutical CDMO Service Revenue Share by Players (2018-2023)
Table 18. Global Top Biopharmaceutical CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2022)
Table 19. Global Biopharmaceutical CDMO Service Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Biopharmaceutical CDMO Service Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Biopharmaceutical CDMO Service, Headquarters and Area Served
Table 22. Global Key Players of Biopharmaceutical CDMO Service, Product and Application
Table 23. Global Key Players of Biopharmaceutical CDMO Service, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Biopharmaceutical CDMO Service Revenue Market Share by Type (2018-2023)
Table 27. Global Biopharmaceutical CDMO Service Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Biopharmaceutical CDMO Service Revenue Market Share by Type (2024-2033)
Table 29. Global Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Biopharmaceutical CDMO Service Revenue Share by Application (2018-2023)
Table 31. Global Biopharmaceutical CDMO Service Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Biopharmaceutical CDMO Service Revenue Share by Application (2024-2033)
Table 33. North America Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Biopharmaceutical CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Biopharmaceutical CDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Biopharmaceutical CDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Biopharmaceutical CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Biopharmaceutical CDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Biopharmaceutical CDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Biopharmaceutical CDMO Service Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Biopharmaceutical CDMO Service Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Biopharmaceutical CDMO Service Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 65. KBI Biopharma Company Details
Table 66. KBI Biopharma Business Overview
Table 67. KBI Biopharma Biopharmaceutical CDMO Service Product
Table 68. KBI Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 69. KBI Biopharma Recent Developments
Table 70. INCOG BioPharma Services Company Details
Table 71. INCOG BioPharma Services Business Overview
Table 72. INCOG BioPharma Services Biopharmaceutical CDMO Service Product
Table 73. INCOG BioPharma Services Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 74. INCOG BioPharma Services Recent Developments
Table 75. CordenPharma Company Details
Table 76. CordenPharma Business Overview
Table 77. CordenPharma Biopharmaceutical CDMO Service Product
Table 78. CordenPharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 79. CordenPharma Recent Developments
Table 80. AGC Biologics Company Details
Table 81. AGC Biologics Business Overview
Table 82. AGC Biologics Biopharmaceutical CDMO Service Product
Table 83. AGC Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 84. AGC Biologics Recent Developments
Table 85. Northway Biotech Company Details
Table 86. Northway Biotech Business Overview
Table 87. Northway Biotech Biopharmaceutical CDMO Service Product
Table 88. Northway Biotech Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 89. Northway Biotech Recent Developments
Table 90. PlantForm Corp Company Details
Table 91. PlantForm Corp Business Overview
Table 92. PlantForm Corp Biopharmaceutical CDMO Service Product
Table 93. PlantForm Corp Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 94. PlantForm Corp Recent Developments
Table 95. Lonza Company Details
Table 96. Lonza Business Overview
Table 97. Lonza Biopharmaceutical CDMO Service Product
Table 98. Lonza Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 99. Lonza Recent Developments
Table 100. ADL Biopharma Company Details
Table 101. ADL Biopharma Business Overview
Table 102. ADL Biopharma Biopharmaceutical CDMO Service Product
Table 103. ADL Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 104. ADL Biopharma Recent Developments
Table 105. Catalent Company Details
Table 106. Catalent Business Overview
Table 107. Catalent Biopharmaceutical CDMO Service Product
Table 108. Catalent Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 109. Catalent Recent Developments
Table 110. Future Fields Company Details
Table 111. Future Fields Business Overview
Table 112. Future Fields Biopharmaceutical CDMO Service Product
Table 113. Future Fields Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 114. Future Fields Recent Developments
Table 115. Vetter Pharma Company Details
Table 116. Vetter Pharma Business Overview
Table 117. Vetter Pharma Biopharmaceutical CDMO Service Product
Table 118. Vetter Pharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 119. Vetter Pharma Recent Developments
Table 120. Stelis Company Details
Table 121. Stelis Business Overview
Table 122. Stelis Biopharmaceutical CDMO Service Product
Table 123. Stelis Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 124. Stelis Recent Developments
Table 125. Richter-Helm Company Details
Table 126. Richter-Helm Business Overview
Table 127. Richter-Helm Biopharmaceutical CDMO Service Product
Table 128. Richter-Helm Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 129. Richter-Helm Recent Developments
Table 130. FUJIFILM Diosynth Biotechnologies Company Details
Table 131. FUJIFILM Diosynth Biotechnologies Business Overview
Table 132. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product
Table 133. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 134. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 135. Cambrex Company Details
Table 136. Cambrex Business Overview
Table 137. Cambrex Biopharmaceutical CDMO Service Product
Table 138. Cambrex Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 139. Cambrex Recent Developments
Table 140. Pfizer CentreOne Company Details
Table 141. Pfizer CentreOne Business Overview
Table 142. Pfizer CentreOne Biopharmaceutical CDMO Service Product
Table 143. Pfizer CentreOne Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 144. Pfizer CentreOne Recent Developments
Table 145. Samsung Biologics Company Details
Table 146. Samsung Biologics Business Overview
Table 147. Samsung Biologics Biopharmaceutical CDMO Service Product
Table 148. Samsung Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 149. Samsung Biologics Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CDMO Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Biopharmaceutical CDMO Service Market Share by Type: 2022 VS 2033
Figure 3. Develop Innovative Drugs Features
Figure 4. Listed Patented Drug Features
Figure 5. Biosimilars Features
Figure 6. Others Features
Figure 7. Global Biopharmaceutical CDMO Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Biopharmaceutical CDMO Service Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. Others Case Studies
Figure 12. Biopharmaceutical CDMO Service Report Years Considered
Figure 13. Global Biopharmaceutical CDMO Service Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Biopharmaceutical CDMO Service Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Biopharmaceutical CDMO Service Market Share by Region: 2022 VS 2033
Figure 16. Global Biopharmaceutical CDMO Service Market Share by Players in 2022
Figure 17. Global Top Biopharmaceutical CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical CDMO Service Revenue in 2022
Figure 19. North America Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 21. North America Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 22. North America Biopharmaceutical CDMO Service Market Share by Country (2018-2033)
Figure 23. United States Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Biopharmaceutical CDMO Service Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 27. Europe Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 28. Europe Biopharmaceutical CDMO Service Market Share by Country (2018-2033)
Figure 29. Germany Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Biopharmaceutical CDMO Service Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 37. China Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 38. Asia Biopharmaceutical CDMO Service Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 40. Asia Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 41. Asia Biopharmaceutical CDMO Service Market Share by Region (2018-2033)
Figure 42. Japan Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Biopharmaceutical CDMO Service Market Share by Country (2018-2033)
Figure 52. Brazil Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Biopharmaceutical CDMO Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 59. INCOG BioPharma Services Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 60. CordenPharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 61. AGC Biologics Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 62. Northway Biotech Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 63. PlantForm Corp Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 64. Lonza Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 65. ADL Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 66. Catalent Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 67. Future Fields Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 68. Vetter Pharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 69. Stelis Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 70. Richter-Helm Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 71. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 72. Cambrex Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 73. Pfizer CentreOne Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 74. Samsung Biologics Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries